Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polymyalgia rheumatica].

Pál Kaposi Novák1, Zsuzsa Schmidt

  • 1Országos Reumatológiai és Fizioterápiás Intézet, Radiológiai Osztály, Budapest.

Orvosi Hetilap
|November 30, 2006
PubMed
Summary

Polymyalgia rheumatica (PMR) is an inflammatory disorder primarily affecting individuals over 50, causing pain and stiffness. Early diagnosis and corticosteroid treatment are key for managing PMR symptoms and inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cumulative Effect of Metabolic Factors on Hepatic Steatosis.

Diagnostics (Basel, Switzerland)·2025
Same author

Acute hydrocephalus caused by a colloid cyst - a case report.

International journal of emergency medicine·2023
Same author

[Polymyalgia rheumatica update, 2015].

Orvosi hetilap·2015
Same author

High frequency of brachiocephalic trunk stent fractures does not impair clinical outcome.

Journal of vascular surgery·2013
Same author

Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.

Acta radiologica (Stockholm, Sweden : 1987)·2013
Same author

A clinical feasibility study to evaluate the safety and efficacy of PEOT/PBT implants for human donor site filling during mosaicplasty.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2013

Area of Science:

  • Rheumatology and Immunology
  • Inflammatory disorders
  • Musculoskeletal conditions

Context:

  • Polymyalgia rheumatica (PMR) is a common inflammatory condition predominantly affecting individuals over 50 years of age.
  • The exact etiology of PMR remains unclear, with an incidence ranging from 0.1-0.5% in those over 50, peaking between 60-70 years.
  • PMR shares clinical and epidemiological features with giant cell arteritis (GCA), often co-occurring in patients and affecting similar demographics.

Purpose:

  • To elucidate the clinical presentation, diagnostic criteria, and potential associations of Polymyalgia Rheumatica (PMR).
  • To explore the relationship between PMR and giant cell arteritis (GCA).
  • To review current understanding of PMR's pathophysiology and treatment strategies.

Summary:

  • PMR diagnosis relies on characteristic symptoms like shoulder and hip girdle pain and stiffness, though limb complaints can occur.
  • Inflammation of joints and periarticular structures is evident on imaging, and acute phase reactants (ESR, CRP, IL-6) are key indicators, though normal levels do not exclude PMR.
  • PMR shows a rapid, positive response to corticosteroid therapy, typically lasting 1-2 years, with alternatives like methotrexate and anti-TNF-alpha agents considered for steroid-sparing.

Impact:

  • Understanding PMR's link to GCA is crucial for timely diagnosis and management of both conditions.
  • Effective management of PMR involves prompt corticosteroid treatment, significantly improving patient outcomes.
  • Further research, including multicenter trials, is needed to refine treatment protocols and explore alternative therapies for PMR.

Related Experiment Videos